Xiaoming Meng, Ph.D.
Affiliations: | 2012 | Medical Sciences | The Chinese University of Hong Kong, Hong Kong, Hong Kong |
Area:
PathologyGoogle:
"Xiaoming Meng"Parents
Sign in to add mentor| Hui Y. Lan | grad student | 2012 | Chinese University of Hong Kong | |
| (Dissection of TGF-beta/Smads in the Renal Inflammation and Fibrosis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Suo XG, Wang JN, Zhu Q, et al. (2025) METTL3 mediated m6A modification of HKDC1 promotes renal injury and inflammation in lead nephropathy. International Journal of Biological Sciences. 21: 3755-3775 |
| Yu JT, Xie SS, Shen XY, et al. (2025) Renal tubular epithelial IGFBP7 interacts with PKM2 to drive renal lipid accumulation and fibrosis. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Meng XM, Wang L, Nikolic-Paterson DJ, et al. (2025) Innate immune cells in acute and chronic kidney disease. Nature Reviews. Nephrology |
| Wang JN, Suo XG, Yu JT, et al. (2025) exacerbates acute renal inflammation by enhancing N4-acetylcytidine modification of the CCL2/CXCL1 axis. Proceedings of the National Academy of Sciences of the United States of America. 122: e2418409122 |
| Xie SS, Hou R, Gao L, et al. (2025) Insulin-Like Growth Factor-Binding Protein 7 and Cadmium-Induced Hepatorenal Fibrosis. Journal of the American Society of Nephrology : Jasn |
| Wei J, Chen XY, Wang ZJ, et al. (2025) Galloflavin mitigates acute kidney injury by suppressing LDHA-dependent macrophage glycolysis. International Immunopharmacology. 150: 114265 |
| Wang Y, You YK, Guo J, et al. (2024) C-reactive protein promotes diabetic kidney disease via Smad3-mediated NLRP3 inflammasome activation. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| He RB, Li W, Yao R, et al. (2024) Aurantiamide mitigates acute kidney injury by suppressing renal necroptosis and inflammation via GRPR-dependent mechanism. International Immunopharmacology. 139: 112745 |
| Wang F, Suo XG, Wang JN, et al. (2024) SFN promotes renal fibrosis via binding with MYH9 in chronic kidney disease. European Journal of Pharmacology. 176806 |
| Chen L, Wang R, Lv X, et al. (2024) Hepatic-derived BMP9 is involved in hepatic fibrosis-induced kidney injury through inhibition of renal VEGFA. Biochemical Pharmacology. 116371 |